EVI sends seasonal greetings to all our partners, colleagues, friends past and present.
European Commission supports project that will define a new vision for vaccine research in Europe and proposes strategies for its achievement
Brussels, 20th December 2013
EVI sends sincere thanks to speakers, chairs, facilitators and to all participants, who helped to make the 2013 RdV a memorable event. We hope to see you again this year.
Final agendaList of participants
At its recent Board meeting, 5 December 2013, the Board approved Alister Craig, Liverpool School of Tropical Medicine as Chair of EVI SAC.
Two Vice Chairs were also approved: Long time member, Ingileif Jónsdóttir, Landspitali University Hospital and Faculty of Medicine, University of Iceland, and James Robertson, retired, who joined SAC this year.
The new Chair of the Board is Clemens Kocken, Biomedical Primate Research Centre
European Commission supports EDUFLUVAC project to develop an innovative vaccine against influenza.
14 November 2013 sees the launch by EVI and WHO and the Malaria Vaccine Funders Group of the updated Malaria Vaccine Technology Roadmap
Link to full text in The Lancet
See also following links:WHO WHO ImmunizationWHO Intl. Malaria
New global strategy for prevention of death and disease from malaria
Heidelberg/Washington, 14 November 2013
Update of the Malaria Vaccine Technology Roadmap aims for effective malaria vaccines by 2030
Medical Research Council (MRC) announces the captioned two week course to be held at the Uganda Virus Research Institute (UVRI), Entebbe.
The EVI Annual Report 2012 is just one click away.
An inter-active user friendly version on a USB stick will be widely distributed during the coming days. Would you like to receive a copy, but are not sure whether you are on the mailing list, please contactusateuvaccine.eu.
Professor Tom Ottenhoff, member of the steering committee of the TuBerclosis Vaccine Initiative (TBVI), received the Eijkman Medal 2013 on 16 October at the Dutch Royal Tropical Institute
EVI round table on "The Challenge of Developing a Pregnancy Associated Malaria Vaccine" was a great success with many comments and an active discussion among the 70-80 participants.